Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders for Globus Medical, Inc., held on June 17, 2015. The filing details the results of shareholder votes on director elections and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
No material financial changes are reported in this document. The primary events are the election of directors and the approval of executive compensation.
Outlook, Risks, and Unusual Items
Proposal 1: Election of Directors
The following nominees were elected to serve three-year terms on the Board of Directors:
- David D. Davidar: 283,194,850 votes For; 9,393,932 votes Against; 92,921 Abstain.
- Robert W. Liptak: 290,967,136 votes For; 1,621,646 votes Against; 92,921 Abstain.
Proposal 2: Executive Compensation
A non-binding advisory vote to approve the compensation of named executive officers was approved with 291,619,945 votes For, 961,867 votes Against, and 99,891 Abstain.
Investor Verification Checklist
- Verify the full slate of directors elected and their respective terms.
- Review the definitive proxy statement (Schedule 14A) for details on the executive compensation package approved in Proposal 2.
- Confirm the total number of shares outstanding and voting rights to contextualize the vote counts.